Sponsored by:

Nuclear Medicine: Page 159

AECL resumes Mo-99 production
By AuntMinnie.com staff writers
Atomic Energy of Canada (AECL) resumed production of the radioisotope molybdenum-99 (Mo-99) over the weekend after an unplanned shutdown.
November 24, 2013
Philips recalls Argus, Cirrus gamma cameras
By AuntMinnie.com staff writers
Philips Healthcare is voluntarily recalling its ADAC Argus and ADAC Cirrus nuclear medicine gamma camera systems due to a potentially serious risk to patients.
November 21, 2013
Gamma Medica plans MBI clinical studies
By AuntMinnie.com staff writers
Gamma Medica plans to conduct clinical studies of its LumaGem molecular breast imaging (MBI) system and compare outcomes with competing breast imaging modalities.
November 21, 2013
Convergent launches imaging software update
By AuntMinnie.com staff writers
Image fusion software developer Convergent Imaging Solutions has released UniSyn Image Fusion 3.1, an update to its medical imaging software suite.
November 21, 2013
Piramal signs PET agent deal with Ci-Co Healthcare
By AuntMinnie.com staff writers
Piramal Imaging has entered into a strategic partnership with Ci-Co Healthcare.
November 20, 2013
FDA warns of risks with Lexiscan, Adenoscan stress agents
By Wayne Forrest
The U.S. Food and Drug Administration on November 20 issued a warning about a "rare but serious risk of heart attack and death" with the use of two cardiac nuclear stress test agents made by pharmaceutical developer Astellas.
November 19, 2013
2013 09 06 11 46 32 375 Fda Logo 200
2 Mo-99 suppliers report unexpected shutdowns
By AuntMinnie.com staff writers
Two sources of the radioisotope molybdenum-99 (Mo-99) are reporting unanticipated supply interruptions.
November 19, 2013
SNMMI announces new orphan drug
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced that a new radiopharmaceutical has been designated as an orphan drug by the U.S. Food and Drug Administration.
November 17, 2013
PET utilization fluctuates between market segments
By Wayne Forrest
Wednesday, December 4 | 3:50 p.m.-4:00 p.m. | SSM17-06 | Room S505ABPET utilization is growing among certain imaging specialties, but it's taking a hit among traditional users, according to research from Jefferson University Hospitals to be presented in this RSNA 2013 session.
November 13, 2013
DWI-MRI matches PET/CT in lymph node evaluation
By Wayne Forrest
Wednesday, December 4 | 3:10 p.m. - 3:20 p.m. | SSM17-02 | Room S505ABDiffusion-weighted MRI (DWI-MRI) is a viable, radiation-free alternative for evaluating lymph nodes, with findings that closely parallel those of FDG-PET/CT, researchers in India have concluded.
November 13, 2013
FDG-PET/CT tops MRI in colon cancer staging
By Wayne Forrest
Wednesday, December 4 | 3:00 p.m.-3:10 p.m. | SSM17-01 | Room S505ABWhile whole-body MRI is a feasible method for staging colon cancer patients, the modality does not quite reach the accuracy of FDG-PET/CT, according to a new study by Italian researchers.
November 13, 2013
PET/MRI complements PET/CT in NSCLC assessment
By Wayne Forrest
Wednesday, December 4 | 11:40 a.m.-11:50 a.m. | SSK17-08 | Room S505ABPET/MRI using a dedicated pulmonary MRI protocol and PET/CT show good agreement on thoracic tumor-node-metastasis staging for non-small cell lung cancer (NSCLC) patients, according to a study from Germany.
November 13, 2013
Previous Page
Page 159 of 439
Next Page